HERMETIC WAFER-TO-WAFER BONDING WITH ELECTRICAL INTERCONNECTION
An implantable medical device (IMD) is disclosed. The IMD includes a first substrate having a front side and a backside. A first via is formed in the front side, the via extending from a bottom point in the front side to a first height located at a surface of the front side. A first conductive pad is formed in the first via, the first conductive pad having an exposed top surface lower than first height. A second substrate is coupled to the first substrate, the second substrate having a second via formed in the front side, the via extending from a bottom point in the front side to a second height located at a surface of the front side. A second conductive pad is formed in the second via, the second conductive pad having an exposed top surface lower than second height. The coupled substrates are heated until a portion of one or both conductive pads reflow, dewet, agglomerate, and merge to form an interconnect, hermetic seal, or both depending on the requirements of the device.
Latest Medtronic, Inc. Patents:
The present disclosure relates generally to creating electrical interconnections between materials, and, more particularly, to creating electrical interconnections between materials that are compatible with low temperature hermetic wafer-to-wafer bonds. Additionally, the methods described herein can be applied to creating hermetic metal seals between wafers.
BACKGROUNDMany electronic components use integrated circuits or chips. An IC is comprised of semiconductor devices (e.g. diode, transistor etc.) and passive components (e.g., transistors, capacitors, resistors, etc.) that are formed in the surface of a thin substrate of semiconductor material.
One IC can be connected to another IC or other wafer through wafer to wafer bonds. Wafer to wafer bonds relates to joining major surfaces of the wafers. The joined areas of the wafers creates the hermetic seal(s).
One type of wafer to wafer bond relies on a copper pad disposed on each wafer. The copper pad is higher than the surrounding plane of the wafer. A copper pad on one wafer is aligned with the copper pad on the other wafer. Thermo-compression diffusion bonding can be employed to join the copper pads located on each wafer. The ICs are then sealed together with a copper seal ring or a race track near the outer edges of the individual chips. Copper is not biostable and may not provide an adequate seal in vivo for implantable medical devices. Additionally, copper pads that are coplanar with a thermal oxide can be difficult to planarize and polish. For example, copper and thermal oxide can have different polishing rates. It is therefore desirable to develop new techniques for efficiently and hermetically sealing the electronic circuitry in IMDs.
SUMMARYThe present disclosure relates to an implantable medical device (IMD) that includes one or more integrated circuits. At least one integrated circuit includes a first substrate bonded to a second substrate. The first substrate has a front side and a backside. A first via is formed in the front side. The via extends from a bottom point to a first height located at a surface of the front side. A first conductive pad is formed in the first via. The first conductive pad has a bottom surface and a top surface. The first conductive pad has an exposed top surface lower than the first height of the via. In one or more embodiments, the second substrate has a second via formed in the front side. The via extends from a bottom point to a second height located at a surface of the front side. A second conductive pad is formed in the second via. The second conductive pad has an exposed top surface lower than second height. Heat is applied to the first and second substrates, which in response causes the first and second conductive pads to flow and form a single reflowed interconnect between the first and second substrates.
In one or more other embodiments, a method is disclosed for forming an integrated circuit for an implantable medical device. In one or more embodiments, a first via is formed in a first side of a first substrate. A first conductive pad is then deposited in the first via. An exposed top surface of the first conductive pad is lower than a top surface of the first via. In one or more embodiments, a second via is formed in a first side of a second substrate. A second conductive pad is deposited in the second via. An exposed top surface of the second conductive pad is lower than a top surface of the second via. Heat is applied which causes the portions of the first and second conductive pads to dewet. For example, portions of the first and second conductive pads can dewet in areas in which the pads are deposited on an insulator such as glass, (also referred to as thermal oxide (i.e. SiO2). In response to having a first and second conductive pad that have an exposed surface below the height of each corresponding via and to the heat, a conductive agglomeration or a single reflowed interconnect forms between and joins together first and second conductive pads The join together. The conductive interconnect formed between the first and second substrates can be dome shaped, hour glass shaped, or spherically shaped. The conductive interconnect creates a mechanical and electrical interconnect between the first and second substrates. Multiple interconnects can be formed in this manner between the first and second substrates. When cooled, the resultant interconnected device can be produced.
In one or more other embodiments, a racetrack can be formed around the periphery of the device in the same fashion as described between first and second conductive pads disposed in the first and second substrates. After heating and cooling, a hermetic seal is formed along the racetrack. The hermetic seal formed along the racetrack eliminates the need for additional packaging that is typically found in conventional devices due to the hermetic seal formed by the racetrack. The lack of additional packaging allows the device to be significantly reduced in size compared to conventional devices.
In one or more embodiments, the first and/or second substrates are formed from biostable wafers such as glass or silicon. For example, the first substrate bonded to the second substrate can be glass-glass, glass-silicon, or silicon-silicon bonding are formed across an entire wafer with the exception of small recessed areas containing the pad structures and racetrack or seal as it will be known hereafter.
In one or more embodiments, the first and/or second conductive pads are supported by an underlying adhesion or barrier material. Adhesion material can comprise transition metal elements such as chromium and/or titanium along with a wettable material such as gold. The first conductive pad such as gold tin (AuSn) is deposited in a thin layer over the wettable pad and the area of the AuSn deposit is larger than the wettable pad. The top of the AuSn metallization remains below the upper surface of the wafer so as not to interfere with the wafer bonding. After or during wafer bonding, the temperature is raised above the melting point of the AuSn (˜280 C). The AuSn dewets from the glass surrounding the gold pad and can form a substantially spherical or dome shape on the pad. The height of this solder bump or ball is determined by the size of the pad and the area and volume of AuSn deposited over the pad and surrounding glass. During melting, the top of the AuSn ball joins to a similar AuSn ball, or to a wettable pad on the mating wafer. The same or similar process can be used to create a seal around the periphery of the device.
The present disclosure depicted in
It will be apparent that elements from one embodiment may be used in combination with elements of the other embodiments, and that the possible embodiments of such apparatus using combinations of features set forth herein is not limited to the specific embodiments shown in the Figures and/or described herein. Further, it will be recognized that the embodiments described herein may include many elements that are not necessarily shown to scale. Further, it will be recognized that the size and shape of various elements herein may be modified but still fall within the scope of the present disclosure, although one or more shapes and/or sizes, or types of elements, may be advantageous over others.
Leads 18, 20, 22 extend into the heart 12 of patient 16 to sense electrical activity of heart 12 and/or deliver electrical stimulation to heart 12. In the example shown in
IMD 16 may sense electrical signals attendant to the depolarization and repolarization of heart 12 via electrodes (not shown in
In some examples, programmer 24 may be a handheld computing device or a computer workstation. Programmer 24 may include a user interface that receives input from a user. The user interface may include, for example, a keypad and a display, which may for example, be a cathode ray tube (CRT) display, a liquid crystal display (LCD) or light emitting diode (LED) display. The keypad may take the form of an alphanumeric keypad or a reduced set of keys associated with particular functions. Programmer 24 can additionally or alternatively include a peripheral pointing device, such as a mouse, via which a user may interact with the user interface. In some embodiments, a display of programmer 24 may include a touch screen display, and a user may interact with programmer 24 via the display.
A user, such as a physician, technician, or other clinician, may interact with programmer 24 to communicate with IMD 16. For example, the user may interact with programmer 24 to retrieve physiological or diagnostic information from IMD 16. A user may also interact with programmer 24 to program IMD 16, e.g., select values for operational parameters of the IMD.
For example, the user may use programmer 24 to retrieve information from IMD 16 regarding the rhythm of heart 12, trends therein over time, or tachyarrhythmia episodes. As another example, the user may use programmer 24 to retrieve information from IMD 16 regarding other sensed physiological parameters of patient 14, such as intracardiac or intravascular pressure, activity, posture, respiration, or thoracic impedance. As another example, the user may use programmer 24 to retrieve information from IMD 16 regarding the performance or integrity of IMD 16 or other components of system 10, such as leads 18, 20, and 22, or a power source of IMD 16.
The user may use programmer 24 to program a therapy progression, select electrodes used to deliver defibrillation shocks, select waveforms for the defibrillation shock, or select or configure a fibrillation detection algorithm for IMD 16. The user may also use programmer 24 to program aspects of other therapies provided by IMD 14, such as cardioversion or pacing therapies. In some examples, the user may activate certain features of IMD 16 by entering a single command via programmer 24, such as depression of a single key or combination of keys of a keypad or a single point-and-select action with a pointing device.
IMD 16 and programmer 24 may communicate via wireless communication using any techniques known in the art. Examples of communication techniques may include, for example, low frequency or radiofrequency (RF) telemetry, but other techniques are also contemplated. In some examples, programmer 24 may include a programming head that may be placed proximate to the patient's body near the IMD 16 implant site in order to improve the quality or security of communication between IMD 16 and programmer 24.
Each of the leads 18, 20, 22 includes an elongated insulative lead body, which may carry a number of concentric coiled conductors separated from one another by tubular insulative sheaths. In the illustrated example, a pressure sensor 38 and bipolar electrodes 40 and 42 are located proximate to a distal end of lead 18. In addition, bipolar electrodes 44 and 46 are located proximate to a distal end of lead 20 and bipolar electrodes 48 and 50 are located proximate to a distal end of lead 22. In
Electrodes 40, 44 and 48 may take the form of ring electrodes, and electrodes 42, 46 and 50 may take the form of extendable helix tip electrodes mounted retractably within insulative electrode heads 52, 54 and 56, respectively. Each of the electrodes 40, 42, 44, 46, 48 and 50 may be electrically coupled to a respective one of the coiled conductors within the lead body of its associated lead 18, 20, 22, and thereby coupled to respective ones of the electrical contacts on the proximal end of leads 18, 20 and 22.
Electrodes 40, 42, 44, 46, 48 and 50 may sense electrical signals attendant to the depolarization and repolarization of heart 12. The electrical signals are conducted to IMD 16 via the respective leads 18, 20, 22. In some examples, IMD 16 also delivers pacing pulses via electrodes 40, 42, 44, 46, 48 and 50 to cause depolarization of cardiac tissue of heart 12. In some examples, as illustrated in
As described in further detail with reference to
Leads 18, 20, 22 also include elongated electrodes 62, 64, 66, respectively, which may take the form of a coil. IMD 16 may deliver defibrillation shocks to heart 12 via any combination of elongated electrodes 62, 64, 66, and housing electrode 58. Electrodes 58, 62, 64, 66 may also be used to deliver cardioversion pulses to heart 12. Electrodes 62, 64, 66 may be fabricated from any suitable electrically conductive material, such as, but not limited to, platinum, platinum alloy or other materials known to be usable in implantable defibrillation electrodes.
Pressure sensor 38 may be coupled to one or more coiled conductors within lead 18. In
The configuration of therapy system 10 illustrated in
In other examples of therapy systems that provide electrical stimulation therapy to heart 12, a therapy system may include any suitable number of leads coupled to IMD 16, and each of the leads may extend to any location within or proximate to heart 12. For example, other examples of therapy systems may include three transvenous leads located as illustrated in
Processor 80 may include any one or more of a microprocessor, a controller, digital signal processor (DSP), an application specific integrated circuit (ASIC), a field-programmable gate array (FPGA), or equivalent discrete or integrated logic circuitry. In some examples, processor 80 may include multiple components, such as any combination of one or more microprocessors, one or more controllers, one or more DSPs, one or more ASICs, or one or more FPGAs, as well as other discrete or integrated logic circuitry. The functions attributed to processor 80 herein may be embodied as software, firmware, hardware or any combination thereof. Processor 80 controls stimulation generator 84 to deliver stimulation therapy to heart 12 according to a selected one or more of therapy programs, which may be stored in memory 82. Specifically, processor 44 may control stimulation generator 84 to deliver electrical pulses with the amplitudes, pulse widths, frequency, or electrode polarities specified by the selected one or more therapy programs.
Stimulation generator 84 is electrically coupled to electrodes 40, 42, 44, 46, 48, 50, 58, 62, 64, and 66, e.g., via conductors of the respective lead 18, 20, 22, or, in the case of housing electrode 58, via an electrical conductor disposed within housing 60 of IMD 16. Stimulation generator 84 is configured to generate and deliver electrical stimulation therapy to heart 12. For example, stimulation generator 84 may deliver defibrillation shocks to heart 12 via at least two electrodes 58, 62, 64, 66. Stimulation generator 84 may deliver pacing pulses via ring electrodes 40, 44, 48 coupled to leads 18, 20, and 22, respectively, and/or helical electrodes 42, 46, and 50 of leads 18, 20, and 22, respectively. In some examples, stimulation generator 84 delivers pacing, cardioversion, or defibrillation stimulation in the form of electrical pulses. In other examples, stimulation generator may deliver one or more of these types of stimulation in the form of other signals, such as sine waves, square waves, or other substantially continuous time signals.
Stimulation generator 84 may include a switch module and processor 80 may use the switch module to select, e.g., via a data/address bus, which of the available electrodes are used to deliver defibrillation shocks or pacing pulses. The switch module may include a switch array, switch matrix, multiplexer, or any other type of switching device suitable to selectively couple stimulation energy to selected electrodes.
Sensing module 86 monitors signals from at least one of electrodes 40, 42, 44, 46, 48, 50, 58, 62, 64 or 66 in order to monitor electrical activity of heart 12, e.g., via electrocardiogram (ECG) signals. Sensing module 86 may also include a switch module to select which of the available electrodes are used to sense the heart activity. In some examples, processor 80 may select the electrodes that function as sense electrodes via the switch module within sensing module 86, e.g., by providing signals via a data/address bus. In some examples, sensing module 86 includes one or more sensing channels, each of which may comprises an amplifier. In response to the signals from processor 80, the switch module of within sensing module 86 may couple the outputs from the selected electrodes to one of the sensing channels.
In some examples, one channel of sensing module 86 may include an R-wave amplifier that receives signals from electrodes 40 and 42, which are used for pacing and sensing in right ventricle 28 of heart 12. Another channel may include another R-wave amplifier that receives signals from electrodes 44 and 46, which are used for pacing and sensing proximate to left ventricle 32 of heart 12. In some examples, the R-wave amplifiers may take the form of an automatic gain controlled amplifier that provides an adjustable sensing threshold as a function of the measured R-wave amplitude of the heart rhythm.
In addition, in some examples, one channel of sensing module 86 may include a P-wave amplifier that receives signals from electrodes 48 and 50, which are used for pacing and sensing in right atrium 26 of heart 12. In some examples, the P-wave amplifier may take the form of an automatic gain controlled amplifier that provides an adjustable sensing threshold as a function of the measured P-wave amplitude of the heart rhythm. Examples of R-wave and P-wave amplifiers are described in U.S. Pat. No. 5,117,824 to Keimel et al., which issued on Jun. 2, 1992 and is entitled, “APPARATUS FOR MONITORING ELECTRICAL PHYSIOLOGIC SIGNALS,” and is incorporated herein by reference in its entirety. Other amplifiers may also be used. Furthermore, in some examples, one or more of the sensing channels of sensing module 86 may be selectively coupled to housing electrode 58, or elongated electrodes 62, 64, or 66, with or instead of one or more of electrodes 40, 42, 44, 46, 48 or 50, e.g., for unipolar sensing of R-waves or P-waves in any of chambers 26, 28, or 32 of heart 12.
In some examples, sensing module 86 includes a channel that comprises an amplifier with a relatively wider pass band than the R-wave or P-wave amplifiers. Signals from the selected sensing electrodes that are selected for coupling to this wide-band amplifier may be provided to a multiplexer, and thereafter converted to multi-bit digital signals by an analog-to-digital converter for storage in memory 82 as an electrogram (EGM). In some examples, the storage of such EGMs in memory 82 may be under the control of a direct memory access circuit. Processor 80 may employ digital signal analysis techniques to characterize the digitized signals stored in memory 82 to detect and classify the patient's heart rhythm from the electrical signals. Processor 80 may detect and classify the heart rhythm of patient 14 by employing any of the numerous signal processing methodologies known in the art.
If IMD 16 is configured to generate and deliver pacing pulses to heart 12, processor 80 may include pacer timing and control module, which may be embodied as hardware, firmware, software, or any combination thereof. The pacer timing and control module may comprise a dedicated hardware circuit, such as an ASIC, separate from other processor 80 components, such as a microprocessor, or a software module executed by a component of processor 80, which may be a microprocessor or ASIC. The pacer timing and control module may include programmable counters which control the basic time intervals associated with DDD, WI, DVI, VDD, AAI, DDI, DDDR, VVIR, DVIR, VDDR, AAIR, DDIR and other modes of single and dual chamber pacing. In the aforementioned pacing modes, “D” may indicate dual chamber, “V” may indicate a ventricle, “I” may indicate inhibited pacing (e.g., no pacing), and “A” may indicate an atrium. The first letter in the pacing mode may indicate the chamber that is paced, the second letter may indicate the chamber in which an electrical signal is sensed, and the third letter may indicate the chamber in which the response to sensing is provided.
Intervals defined by the pacer timing and control module within processor 80 may include atrial and ventricular pacing escape intervals, refractory periods during which sensed P-waves and R-waves are ineffective to restart timing of the escape intervals, and the pulse widths of the pacing pulses. As another example, the pace timing and control module may define a blanking period, and provide signals from sensing module 86 to blank one or more channels, e.g., amplifiers, for a period during and after delivery of electrical stimulation to heart 12. The durations of these intervals may be determined by processor 80 in response to stored data in memory 82. The pacer timing and control module of processor 80 may also determine the amplitude of the cardiac pacing pulses.
During pacing, escape interval counters within the pacer timing/control module of processor 80 may be reset upon sensing of R-waves and P-waves. Stimulation generator 84 may include pacer output circuits that are coupled, e.g., selectively by a switching module, to any combination of electrodes 40, 42, 44, 46, 48, 50, 58, 62, or 66 appropriate for delivery of a bipolar or unipolar pacing pulse to one of the chambers of heart 12. Processor 80 may reset the escape interval counters upon the generation of pacing pulses by stimulation generator 84, and thereby control the basic timing of cardiac pacing functions, including anti-tachyarrhythmia pacing.
The value of the count present in the escape interval counters when reset by sensed R-waves and P-waves may be used by processor 80 to measure the durations of R-R intervals, P-P intervals, P-R intervals and R-P intervals, which are measurements that may be stored in memory 82. Processor 80 may use the count in the interval counters to detect a tachyarrhythmia event, such as ventricular fibrillation event or ventricular tachycardia event. Upon detecting a threshold number of tachyarrhythmia events, processor 80 may identify the presence of a tachyarrhythmia episode, such as a ventricular fibrillation episode, a ventricular tachycardia episode, or a non-sustained tachycardia (NST) episode.
In some examples, processor 80 may operate as an interrupt driven device, and is responsive to interrupts from pacer timing and control module, where the interrupts may correspond to the occurrences of sensed P-waves and R-waves and the generation of cardiac pacing pulses. Any necessary mathematical calculations to be performed by processor 80 and any updating of the values or intervals controlled by the pacer timing and control module of processor 80 may take place following such interrupts. A portion of memory 82 may be configured as a plurality of recirculating buffers, capable of holding series of measured intervals, which may be analyzed by processor 80 in response to the occurrence of a pace or sense interrupt to determine whether the patient's heart 12 is presently exhibiting atrial or ventricular tachyarrhythmia.
In some examples, an arrhythmia detection method may include any suitable tachyarrhythmia detection algorithms. In one example, processor 80 may utilize all or a subset of the rule-based detection methods described in U.S. Pat. No. 5,545,186 to Olson et al., entitled, “PRIORITIZED RULE BASED METHOD AND APPARATUS FOR DIAGNOSIS AND GREATMENT OF ARRHYTHMIAS,” which issued on Aug. 13, 1996, or in U.S. Pat. No. 5,755,736 to Gillberg et al., entitled, “PRIORITIZED RULE BASED METHOD AND APPARATUS FOR DIAGNOSIS AND TREATMENT OF ARRHYTHMIAS,” which issued on May 26, 1998. U.S. Pat. No. 5,545,186 to Olson et al. and U.S. Pat. No. 5,755,736 to Gillberg et al. are incorporated herein by reference in their entireties. However, other arrhythmia detection methodologies may also be employed by processor 80 in other examples.
In the examples described herein, processor 80 may identify the presence of an atrial or ventricular tachyarrhythmia episode by detecting a series of tachyarrhythmia events (e.g., R-R or P-P intervals having a duration less than or equal to a threshold) of an average rate indicative of tachyarrhythmia or an unbroken series of short R-R or P-P intervals. The thresholds for determining the R-R or P-P interval that indicates a tachyarrhythmia event may be stored within memory 82 of IMD 16. In addition, the number of tachyarrhythmia events that are detected to confirm the presence of a tachyarrhythmia episode may be stored as a number of intervals to detect (NID) threshold value in memory 82. In some examples, processor 80 may also identify the presence of the tachyarrhythmia episode by detecting a variable coupling interval between the R-waves of the heart signal. For example, if the interval between successive tachyarrhythmia events varies by a particular percentage or the differences between the coupling intervals are higher than a given threshold over a predetermined number of successive cycles, processor 80 may determine that the tachyarrhythmia is present.
If processor 80 detects an atrial or ventricular tachyarrhythmia based on signals from sensing module 86, and an anti-tachyarrhythmia pacing regimen is desired, timing intervals for controlling the generation of anti-tachyarrhythmia pacing therapies by stimulation generator 84 may be loaded by processor 80 into the pacer timing and control module to control the operation of the escape interval counters therein and to define refractory periods during which detection of R-waves and P-waves is ineffective to restart the escape interval counters.
If IMD 16 is configured to generate and deliver defibrillation shocks to heart 12, stimulation generator 84 may include a high voltage charge circuit and a high voltage output circuit. In the event that generation of a cardioversion or defibrillation shock is required, processor 80 may employ the escape interval counter to control timing of such cardioversion and defibrillation shocks, as well as associated refractory periods. In response to the detection of atrial or ventricular fibrillation or tachyarrhythmia requiring a cardioversion pulse, processor 80 may activate a cardioversion/defibrillation control module, which may, like pacer timing and control module, be a hardware component of processor 80 and/or a firmware or software module executed by one or more hardware components of processor 80. The cardioversion/defibrillation control module may initiate charging of the high voltage capacitors of the high voltage charge circuit of stimulation generator 84 under control of a high voltage charging control line.
Processor 80 may monitor the voltage on the high voltage capacitor, e.g., via a voltage charging and potential (VCAP) line. In response to the voltage on the high voltage capacitor reaching a predetermined value set by processor 80, processor 80 may generate a logic signal that terminates charging. Thereafter, timing of the delivery of the defibrillation or cardioversion pulse by stimulation generator 84 is controlled by the cardioversion/defibrillation control module of processor 80. Following delivery of the fibrillation or tachycardia therapy, processor 80 may return stimulation generator 84 to a cardiac pacing function and await the next successive interrupt due to pacing or the occurrence of a sensed atrial or ventricular depolarization.
Stimulation generator 84 may deliver cardioversion or defibrillation shocks with the aid of an output circuit that determines whether a monophasic or biphasic pulse is delivered, whether housing electrode 58 serves as cathode or anode, and which electrodes are involved in delivery of the cardioversion or defibrillation shocks. Such functionality may be provided by one or more switches or a switching module of stimulation generator 84.
Telemetry module 88 includes any suitable hardware, firmware, software or any combination thereof for communicating with another device, such as programmer 24 (
In some examples, processor 80 may transmit atrial and ventricular heart signals (e.g., electrocardiogram signals) produced by atrial and ventricular sense amp circuits within sensing module 86 to programmer 24. Programmer 24 may interrogate IMD 16 to receive the heart signals. Processor 80 may store heart signals within memory 82, and retrieve stored heart signals from memory 82. Processor 80 may also generate and store marker codes indicative of different cardiac episodes that sensing module 86 detects, and transmit the marker codes to programmer 24. An example pacemaker with marker-channel capability is described in U.S. Pat. No. 4,374,382 to Markowitz, entitled, “MARKER CHANNEL TELEMETRY SYSTEM FOR A MEDICAL DEVICE,” which issued on Feb. 15, 1983 and is incorporated herein by reference in its entirety.
The various components of IMD 16 are coupled to power source 90, which may include a rechargeable or non-rechargeable battery. A non-rechargeable battery may be selected to last for several years, while a rechargeable battery may be inductively charged from an external device, e.g., on a daily or weekly basis.
A user may use programmer 24 to select therapy programs (e.g., sets of stimulation parameters), generate new therapy programs, modify therapy programs through individual or global adjustments or transmit the new programs to a medical device, such as IMD 16 (
Processor 100 can take the form one or more microprocessors, DSPs, ASICs, FPGAs, programmable logic circuitry, or the like, and the functions attributed to processor 100 herein may be embodied as hardware, firmware, software or any combination thereof. Memory 102 may store instructions. For example, read only memory (ROM) stores computer instructions. Processor 80 is configured to access the computer instructions from ROM and then processor 80 executes the computer instructions. Execution of computer instructions by processor 80 can cause processor 100 to generate control signals to components of the IMD 16 or components electrically and/or mechanically coupled to IMD 16. Processor 80 can provide the functionality ascribed to programmer 24 herein, and information used by processor 100 to provide the functionality ascribed to programmer 24 herein. Memory 102 may include any fixed or removable magnetic, optical, or electrical media, such as RAM, ROM, CD-ROM, hard or floppy magnetic disks, EEPROM, or the like. Memory 102 may also include a removable memory portion that may be used to provide memory updates or increases in memory capacities. A removable memory may also allow patient data to be easily transferred to another computing device, or to be removed before programmer 24 is used to program therapy for another patient. Memory 102 may also store information that controls therapy delivery by IMD 16, such as stimulation parameter values.
Programmer 24 may communicate wirelessly with IMD 16, such as using RF communication or proximal inductive interaction. This wireless communication is possible through the use of telemetry module 102, which may be coupled to an internal antenna or an external antenna. An external antenna that is coupled to programmer 24 may correspond to the programming head that may be placed over heart 12, as described above with reference to
Telemetry module 102 may also be configured to communicate with another computing device via wireless communication techniques, or direct communication through a wired connection. Examples of local wireless communication techniques that may be employed to facilitate communication between programmer 24 and another computing device include RF communication according to the 802.11 or Bluetooth specification sets, infrared communication, e.g., according to the IrDA standard, or other standard or proprietary telemetry protocols. In this manner, other external devices may be capable of communicating with programmer 24 without needing to establish a secure wireless connection.
Power source 108 delivers operating power to the components of programmer 24. Power source 108 may include a battery and a power generation circuit to produce the operating power. In some embodiments, the battery may be rechargeable to allow extended operation. Recharging may be accomplished by electrically coupling power source 108 to a cradle or plug that is connected to an alternating current (AC) outlet. In addition or alternatively, recharging may be accomplished through proximal inductive interaction between an external charger and an inductive charging coil within programmer 24. In other embodiments, traditional batteries (e.g., nickel cadmium or lithium ion batteries) may be used. In addition, programmer 24 may be directly coupled to an alternating current outlet to power programmer 24. Power source 104 may include circuitry to monitor power remaining within a battery. In this manner, user interface 104 may provide a current battery level indicator or low battery level indicator when the battery needs to be replaced or recharged. In some cases, power source 108 may be capable of estimating the remaining time of operation using the current battery.
Referring again to
For example, as previously described, in some examples, processor 80 may identify the presence of a tachyarrhythmia episode by detecting a threshold number of tachyarrhythmia events (e.g., R-R or P-P intervals having a duration less than or equal to a threshold). In some examples, processor 80 may also identify the presence of the tachyarrhythmia episode by detecting a variable coupling interval between the R-waves of the heart signal.
The techniques described in this disclosure, including those attributed to IMD 16, programmer 24, or various constituent components, may be implemented, at least in part, in hardware, software, firmware or any combination thereof. For example, various aspects of the techniques may be implemented within one or more processors, including one or more microprocessors, DSPs, ASICs, FPGAs, or any other equivalent integrated or discrete logic circuitry, as well as any combinations of such components, embodied in programmers, such as physician or patient programmers, stimulators, image processing devices or other devices. The term “processor” or “processing circuitry” may generally refer to any of the foregoing logic circuitry, alone or in combination with other logic circuitry, or any other equivalent circuitry.
Such hardware, software, firmware may be implemented within the same device or within separate devices to support the various operations and functions described in this disclosure. In addition, any of the described units, modules or components may be implemented together or separately as discrete but interoperable logic devices. Depiction of different features as modules or units is intended to highlight different functional aspects and does not necessarily imply that such modules or units must be realized by separate hardware or software components. Rather, functionality associated with one or more modules or units may be performed by separate hardware or software components, or integrated within common or separate hardware or software components.
When implemented in software, the functionality ascribed to the systems, devices and techniques described in this disclosure may be embodied as instructions on a computer-readable medium such as RAM, ROM, NVRAM, EEPROM, FLASH memory, magnetic data storage media, optical data storage media, or the like. The instructions may be executed by one or more processors to support one or more aspects of the functionality described in this disclosure.
Presented in
Referring to
Backside 302b of the silicon substrate 300 is shown to have undergone a grinding and polishing operation so that the backside 302b can receive a scribe, which identifies the wafer as being an individual wafer within a specific lot of wafers. Preferably, about Δy (y2−y1) which is about 1.5 mil of silicon is removed from backside 302b during the grinding operation; however, skilled artisans appreciate that the amount of silicon removed can be adjusted. For example, an increased amount or decreased amount of silicon can be removed depending on the final desired characteristic of backside 302b that undergoes the grinding operation. Grinding equipment manufactured by DISCO, located in Japan can be used to grind a portion of the silicon from backside 302b.
After completion of the grinding operation, the substrate 300 is then loaded into a substrate mover, also referred to as a TEFLON® boat, so that the substrate can be moved into position for a cleaning operation. The substrate mover is configured to hold and move substrate 300 along an x-axis and/or a y-axis direction during the cleaning operation. For example, at operation 2, substrate 300 is placed in a substrate mover which is then positioned into cleaning equipment. The cleaning equipment includes a cleaning spray 301 in which compound(s) are sprayed onto the substrate 300 as shown in
After the substrate 300 has been cleaned, barrier layers 308a (or thermal oxide such as oxide, nitride, etc.) are formed on substrate 300 as shown in
At operation 4, the silicon substrate 300 receives a scribe 306 typically on the backside 302b, as shown in
At operation 5 shown in
At operation 6 shown in
At operation 7 shown in
At operation 8, shown in
In this example, a positive photoresist 310a is employed. An exemplary positive photoresist is commercially available as SPR3010 photoresist from Rohm and Hass located in Philadelphia, Pa. and now a wholly owned subsidiary of Dow Chemical Company.
At operation 9 shown in
At operation 11 shown in
At operation 12 shown in
Thereafter, substrate 300 is moved to the TEFLON® substrate 300 mover so that substrate 300 can undergo yet another cleaning operation. At operation 13 shown in
At operation 14 shown in
Optional operations 15-19, shown in
Soft baking can occur at a temperature of about 95 degrees Celsius for about 60 seconds. Soft-baking helps in photo-imaging and to remove any residual solvents from the photoresist 310c.
At operation 16 shown in
At operation 20 shown in
A wide variety of ways can be employed to deposit the metal or alloy into a via 318. Sputter deposition is an exemplary method that can be used. For example, a first conductive material 322a such as Ti can be deposited into via 318. The first conductive material 322a such as Ti can have a thickness of about 300 Å.
Thereafter, a second conductive material 322b such as gold (Au) can be introduced or deposited over the first conductive material 322a. The second conductive material 322b such as Au can have a thickness of about 5,000 Å.
Typical metal stacks, formed by more than one layer of conductive material, can be Ti/Au/Ti (300/5000/300 Å) or Cr/Au/Ti (300/5000/300 Å) In one or more embodiments, an adhesion layer is always placed onto the barrier material 308d. Typical adhesion layers can be Ti or Cr because gold does not adhere well to an underlying material. Thereafter, gold is placed over the adhesion layer. Finally, a Ti layer is placed on top of the second layer so that subsequent oxide layers will stick or adhere to the metal stack. Generally, oxide does not stick or adhere very well to Au. Thereafter, the top titanium layer is removed where the AuSn is desired to agglomerate but the Ti remains in areas that it is desirable for the oxide to continue to cover, as shown in the figures.
A third conductive material 322c such as chromium (Cr) can be introduced over the second conductive material 322b. For example, Cr can be deposited to a thickness of about 300 Å over the second conductive material 322b. In one or more embodiments, Cr is deposited over the second conductive material 322b through sputtering in which argon is employed. Sputter processes can occur over the wafer at temperatures up to 300° C. The vacuum chamber pressure is typically pumped to 1×10−7 Torr before sputtering begins, and during the processing of argon, pressure is typically 3 to 10 milliTorr. In one or more other embodiments, a thinner layer of second conductive material 322b (e.g. gold etc.) can be formed. For example, the gold material can be about 1000 Å thick. In one or more other embodiments, first, second, and third conductive materials 322a-c can comprise titanium, platinum, and titanium (Ti/Pt/Ti) material, respectively. In one or more embodiments, a preferable thickness is about 300 Å Ti, about 2000 Å Pt, and 300 Å Ti.
In one or more other embodiments, pad 320 (also referred to as conductive pad, solderable pad, or metal stack) can employ nickel vanadium (NiV)/Au/Ti as third conductive material 322c, second conductive material 322b, first conductive material 322a, respectively.
In one or more other embodiments, it is appreciated that pad 320 can be formed of four or more conductive materials. For example, pad 320 can comprise Ti/Pt/Au/Ti in which fourth conductive material (not shown in
In one or more other embodiments, it is appreciated that pad 320 can be formed of four or more conductive materials. For example, pad 320 can comprise Ti/Ni/Au/Ti in which fourth conductive material (not shown in
At operation 21 shown in
A short soft bake is used to harden the photoresist 310d and drive out volatile components from the photoresist. Soft baking can occur at a temperature of about 95° Celsius for about 60 seconds.
At operation 22 shown in
At operation 23 shown in
At operation 24 shown in
At operation 25 shown in
At operation 26 shown in
At operation 27 shown in
At operation 33 shown in
Operations 34-38 shown in
At operation 38 shown in
At operation 39 shown in
The relationship between the pad opening, AuSn diameter and AuSn thickness, and barrier material 308d (e.g. glass) thickness can be shown relative to
The radius of the pad (rpad) opening, (shown in third conductive material 322c of
The height (H340a) of the conductive material 340a ranges from about 0.25 mircon to about 1.0 mircon. More, preferably, the H340a has a height of 0.5 micron. When added to the height of conductive materials 322a, 322b, 322c, and 326 H340a must be, smaller than the height of the via (Hvia) which is preferably 1.5 mircon. Referring to
At operation 40 shown in
The finished wafer 400 can be joined or bonded to another finished wafer 420, as shown by the wafer-to-wafer bond 500 in
The face side 402 of finished wafer 400 is aligned and bonded to the face side 402 of finished wafer 420. Finished wafer 420 can be the same or different as finished wafer 400. For example, finished wafer 420 is different from finished wafer 400 in that finished wafer 402 lacks vias 314b and 318. The first substrate 400 bonded to the second substrate 420 can be a glass to glass bond, glass-silicon bond, silicon-silicon bond, silicon to sapphire, sapphire to sapphire, and/or glass to sapphire. The glass to glass bond, glass-silicon bond, or silicon-silicon bond can be formed across an entire wafer with the exception of small recessed areas containing the pad structures
At operation 41 shown in
At operation 42 shown in
At operation 43 shown in
Table 1 presented below provides a brief description of the process operations used to form a wafer to wafer interconnect and/or seal as described in the text accompanying each figure.
Table 2, presented below, provides experimental data as to the height, radii and volumetric measurements of the vias, and conductive pads. The measurements provided in Table 2 are in microns. For example, height and radii are in units of microns whereas volume is in cubic microns.
In one or more other embodiments, the conductive pad or solderable pad could be gold over titanium or gold over chromium. The underlying titanium or chromium layer(s) need only be thick enough to provide good adhesion. For example, titanium or chromium layer(s) should be in the 100s of Å. Preferably, the range of titanium should be about 100 Angstroms to about 500 Å. Preferably, the range of chromium is about 200 Angstroms to about 500 Å. Titanium would still be employed over the gold in areas covered with glass to improve the adhesion of the glass to the pad.
In yet another embodiment related to the solderable pad, gold could be replaced with platinum. The platinum pad is not consumed by the solder; therefore, the liquidus does not change due to the absorption of the gold. Preferably, the platinum thickness can range from about 100 to about 1000 Å thick. More preferably, the platinum thickness can range from about 100 to about 5000 Å thick. Using platinum in place of gold can be done for both the pad under the AuSn solder as well as a pad to which the AuSn might be joined during solder reflow process described herein.
Conductive pads or bumps can join in the middle of a via. In another embodiment, conductive pads or bumps can be located on one wafer making connection to pads on the mating wafer.
In one or more other embodiments, other metals such as palladium, copper, nickel, rhodium, tin, could be used in place of the gold in the solderable pads.
In one or more embodiments related to solderable pads (the Ti/Au/Ti or equivalent), rather than having the glass overlap the metal and define the conductive pad's 320 perimeter as shown in
As shown in
After a portion 718 of the third conductive material 302 is removed,
The bump to mating metal pad structure 712 undergoes a reflow process to form a low temperature interconnect of reflowed conductive material 726. The reflow process uses a temperature in the chamber of about 305° C. with an inert atmosphere. Generally, the reflow process can take about 3 to about 10 minutes. Generally, the mating metal 712 does not reflow. It simply wets the bump when it agglomerates on the opposing surface. After the reflow process,
Any remaining photoresist (not shown) is stripped from the top surface of the barrier layer 342 through the use of ionized oxygen plasma stripping operation until the exposed photoresist is removed. The oxygen plasma attacks and etches away the organic material (e.g. photoresist) but does not affect the inorganic material (e.g. metal etc.). The stripper processing chamber, under a low pressure vacuum (e.g. 1.5 Torr), continuously removes etched volatilized particles away.
Operations 34-38, shown in
The conductive material 340a (e.g. AuSn) undergoes a reflow process to form reflowed conductive material 340b (
Although various embodiments of the invention have been described and illustrated with reference to specific embodiments thereof, it is not intended that the invention be limited to such illustrative embodiments. For example, it is to be appreciated that while specific examples of the processing equipment are provided, a variety of types of processing equipment can be used. Additionally, skilled artisans appreciate that while a positive photoresist was used in the process described herein, a negative photoresist could be used in place of the positive photoresist. If a negative photoresist is used, the mask should be configured to accommodate the negative photoresist.
Additionally, alternate processes and flows could be used to achieve the same end result. For example, a lift-off process rather than deposit, pattern and etch can be used to form the structures shown in
Combining low temperature hermetic wafer bonding with an electrical interconnection is easier and cheaper to implement than conventional methods. For example, since each conductive pad is placed in a recessed cavity, the conductive pad does not interfere with CMP. Moreover, electrical connections can be provided in any location on the wafer since a solder bump is not placed on the surface of the wafer. Moreover, there is no need to add “dummy” connections merely to provide a uniform distribution of conductive pads across the wafer.
The present disclosure presents various embodiments for creating electrical interconnections between wafers using AuSn or other alloy deposited or otherwise applied to both opposing pads 320 to be connected. The present disclosure can also be applied to a bump-to-pad configuration, as shown in
The bump-to-pad configuration can reduce cost by applying the AuSn to only one wafer rather than both. The bump-to-pad configuration also allows the pad-only wafer to be processed in a manner that might not be compatible with the wafer if the wafer had AuSn on the surface. For example oxygen plasma cleaning or oxidizing acids would oxidize the Sn in the AuSn and hinder a subsequent spherical or ball formation. This configuration however would not affect the wettability of a gold pad on a wafer.
The interconnect is accomplished the same way with the single-sided design as with the two-sided design previously disclosed. Wafers are brought together with pads aligned and the wafer stack is heated above the liquidus (280° C.) of the AuSn. The AuSn will dewet from the glass annulus around the wettable pad and attempt to form a sphere or dome shape to reduce surface energy. The AuSn volume is sufficient to cause the near-spherical AuSn to touch the wettable (most likely gold) pad on the opposing wafer and form the electrical contact. Again, no liquid or paste flux is used or is desired. This can be accomplished during or after the wafer bonding heat activation process.
The 80/20 weight percent AuSn alloy was described previously and is well-suited to this application because of its ability to be deposited, patterned and reflowed without flux. As mentioned previously, oxygen should be eliminated from the atmosphere to preclude oxidation during heating. Other alloys in the AuSn system such as AuSn 78/22 could prove beneficial. The additional Sn content allows the liquid AuSn to consume dissolved gold from the wettable pads without raising the liquidus temperature. This is evident from the AuSn binary phase diagram. AuSn 79/21 and other alloys are possible.
Other suitable alloys could include binary or higher-order combinations of Au, Sn, Ag, etc. Selection of an alloy with a desired liquidus temperature and wetting properties can provide preferable results. It is also understood that while Au is used in many embodiments, Pt can be substituted for Au.
The interconnect method described herein can be applied to any number of wafers properly aligned in a stack. Single and double-sided bonding could even be mixed within the stack. Single and double-sided bonding can be accomplished either serially by the addition of one or more wafers at a time to a previously processed subset of wafers or by processing the entire stack simultaneously.
As used herein, “have”, “having”, “include”, “including”, “comprise”, “comprising” or the like are used in their open ended sense, and generally mean “including, but not limited to”. It will be understood that “consisting essentially of”, “consisting of”, and the like are subsumed in “comprising” and the like. Accordingly, a first conductive material comprising titanium includes a first conductive material consisting essentially of, or consisting of, a titanium.
A variety of components can employ the technology described herein. Sensors (e.g. wireless sensors, leaded sensors), smart leads and/or miniature therapeutic devices exemplify the type of components that can implement the teachings of the present disclosure. The sensor, smart lead or miniature devices may or may not be protected and enclosed in an implantable cardioverter defibrillator (ICD) titanium can or housing. An example of a sensor may be seen with respect to U.S. Pat. No. 7,886,608 issued Feb. 15, 2011, and assigned to the assignee of the present invention, the disclosure of which is incorporated by reference in its entirety herein. An example of a biostable switch may be seen with respect to U.S. Pat. No. 7,388,459 issued Jun. 17, 2008, and assigned to the assignee of the present invention, the disclosure of which is incorporated by reference in its entirety herein. An example of an intravascular device may be seen with respect to U.S. Pregrant Publication 2007/0179552 to Dennis et al. published Aug. 2, 2007, US 2010/0305628 A1 to Lund Et al. and assigned to the assignee of the present invention, the disclosure of which are incorporated by reference in their entirety herein. An example of an implantable neurostimulator may be seen with respect to U.S. Pat. No. 7,809,443 issued Oct. 5, 2010, and assigned to the assignee of the present invention, the disclosure of which is incorporated by reference in its entirety herein. An example of an implantable agent delivery system may be seen with respect to U.S. Pregrant Publication No. 2010/0274221 A1 to Sigg. et al. published Oct. 28, 2010, and assigned to the assignee of the present invention, the disclosure of which is incorporated by reference in its entirety herein.
The description of the invention presented herein is merely exemplary in nature and, thus, variations that do not depart from the gist of the invention are intended to be within the scope of the invention. Variations are not to be regarded as a departure from the spirit and scope of the invention.
Claims
1. A method for forming an integrated circuit comprising:
- providing a first substrate;
- forming a first conductive material that is entirely recessed relative to a surface of the first substrate;
- providing a second substrate;
- forming a second conductive material that is entirely recessed relative to a surface of the second substrate; and
- reflowing at least one of the first and second conductive material to form a single reflowed interconnect between the first and second substrate.
2. The method of claim 1 wherein a hermetic seal is formed between the first and second substrate.
3. The method of claim 1 wherein the single reflowed interconnect is an hour glass shape.
4. The method of claim 1 wherein the first conductive material is a flowable pad which agglomerates toward a diametrically opposing pad.
5. The method of claim 4 wherein the first conductive material is gold-tin (AuSn).
6. The method of claim 4 wherein the second conductive material is one of a flowable pad and a nonflowable pad, the nonflowable pad does not reflow.
7. The method of claim 1 wherein the first and second conductive materials are not copper.
8. The method of claim 1 wherein the first substrate and the second substrate being one of silicon and glass, glass to glass, glass to silicon, silicon to silicon, silicon to sapphire, sapphire to sapphire, and glass to sapphire.
9. The method of claim 5 wherein Au is present in an amount of about 80 weight percent and Sn is present in an amount of 20 weight percent of the AuSn.
10. The method of claim 5 wherein Au is present in an amount of about 78 weight percent and Sn is present in an amount of 22 weight percent of the AuSn.
11. The method of claim 5 wherein one of the first conductive pad and the second conductive pad comprising of palladium, copper, nickel, rhodium, tin, platinum, or gold.
12. An implantable medical device made according to any of the claims 1-11.
13. A pacing lead made according to any of the claims 1-11.
14. A sensor made according to any of the claims 1-11.
15. A communication device made according to any of the claims 1-11.
16. A switch made according to any of the claims 1-11.
17. A method comprising:
- providing a first substrate;
- introducing a first conductive material that is entirely recessed relative to a surface of the first substrate;
- providing a second substrate;
- introducing a second conductive material that is entirely recessed relative to a surface of the second substrate; and
- heating the first and second conductive material to form a single reflowed interconnect between the first and second substrate.
18. The method of claim 17 further comprising forming an integrated circuit.
19. The method of claim 18 wherein the integrated circuit is disposed in an implantable leadless pacemaker.
20. The method of claim 18 wherein the integrated circuit is disposed in an implantable sensor.
21. The method of claim 18 wherein the integrated circuit is disposed in an implantable communication device.
22. The method of claim 18 wherein the integrated circuit is disposed in an implantable relay device.
23. The method of claim 18 wherein the integrated circuit is disposed in a lead body.
24. The method of claim 18 wherein the implantable medical device is a medical electrical lead with at least one integrated circuit disposed in a smart lead.
25. An implantable medical device made according to any of the claim 17.
26. An integrated circuit comprising:
- means for providing a first substrate;
- means for forming a first conductive material that is entirely recessed relative to a surface of the first substrate;
- means for providing a second substrate;
- means for forming a second conductive material that is entirely recessed relative to a surface of the second substrate; and
- means for reflowing at least one of the first and second conductive material to form a single reflowed interconnect between the first and second substrate.
27. The method of claim 26 further comprising forming a hermetic seal between the first and second substrate.
28. The method of claim 26 wherein the single reflowed interconnect is hour glass shaped and dome shaped.
29. The method of claim 26 wherein the first conductive material is AuSn.
Type: Application
Filed: Apr 28, 2011
Publication Date: Nov 3, 2011
Applicant: Medtronic, Inc. (Minneapolis, MN)
Inventors: David A. Ruben (Mesa, AZ), Michael F. Mattes (Chandler, AZ), Jonathan R. Smith (Gilbert, AZ)
Application Number: 13/096,968
International Classification: A61B 5/0402 (20060101); H01L 23/48 (20060101); A61N 1/04 (20060101); H01L 21/762 (20060101);